V
Verastem D
D
VSTM
8.22500
USD
0.50
(6.47%)
مغلق
حجم التداول
139,889
الربح لكل سهم
-3
العائد الربحي
-
P/E
-2
حجم السوق
506,209,846
الأخبار المقالات
العنوان: Verastem
القطاع: Healthcare
الصناعة: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.